EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization ( STOP DIABETES )

John Armato iD, Ralph A DeFronzo iD, Muhammad Abdul-Ghani iD, Ron Ruby

Diabetes, Obesity and Metabolism · 2026-07 · 28 (7) · 5696-5703

DOI: 10.1111/dom.70762 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 13.04.2026. Verfasst von John Armato und 3 weiteren Autor:innen. Beteiligte Einrichtung: Providence Little Company of Mary Cardiometabolic Center, Torrance, California, USA. Hauptthemen laut MEDLINE: Glucose Intolerance, Insulin Resistance, Diabetes Mellitus, Type 2, Insulin. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Insulin resistance is a key pathophysiologic defect in patients with impaired glucose tolerance (IGT) who progress to type 2 diabetes. However, some individuals progress to IGT despite normal total body insulin sensitivity (IS). In patients from the STOP DIABETES trial, physiologic and metabolic features were compared between IS patients manifesting IGT and insulin resistant (IR) patients with IGT.

Methods

From the STOP DIABETES trial population, we identified two groups of IGT subjects: (i) those who were insulin sensitive (IS) ( n = 107) (> 25th percentile of patients with normal glucose tolerance) and (ii) those who were insulin resistant (IR) ( n = 222) (≤ 25th percentile) using the Matsuda index. IS‐IGT patients also were compared to insulin sensitive patients with NGT and 1‐hour (1‐h) plasma glucose < 155 mg/dL ( n = 574).

Results

Compared to the IR‐IGT group, IS IGT individuals had a higher plasma HDL, and lower BMI, plasma triglycerides, triglyceride/HDL ratio, hs‐CRP (all p < 0.001) and normal blood pressure ( p < 0.01). The IS‐IGT group developed IGT with a higher disposition index, p < 0.0001, but the early insulinogenic index was significantly lower than in the IR group ( p < 0.0001) (10.5 ± 0.4 vs. 21.4 ± 0.5, p < 0.0001). Compared with IS‐NGT patients, the IS‐IGT individuals manifested reduced beta cell function and increased insulin clearance.

Conclusion

Approximately one third of patients from the STOP DIABETES study demonstrate impaired glucose tolerance despite having normal insulin sensitivity. This IS‐IGT group had significantly less metabolic dyslipidaemia, less hypertension, better beta cell function and increased insulin clearance compared to insulin resistant IGT patients. Trial Registration ClinicalTrials.gov identifier: number NCT03308773

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucose IntoleranceInsulin ResistanceDiabetes Mellitus, Type 2InsulinHumansFemaleMaleMiddle AgedBlood GlucoseGlucose Tolerance TestTriglyceridesBody Mass IndexInsulin-Secreting Cells

Stichwörter der Autor:innen

beta cell dysfunctionimpaired glucose toleranceinsulin clearanceinsulin resistanceinsulin sensitivemetabolic dyslipidaemiaprediabetes

Substanzen

InsulinBlood GlucoseTriglycerides

Autor:innen und Institutionen

  • Providence Little Company of Mary Cardiometabolic Center, Torrance, California, USA.
  • Diabetes Division, University of Texas Health Science Center, San Antonio, Texas, USA.

ORCID-Profile: John Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani

Zitieren

APA

Armato, J., DeFronzo, R. A., Abdul-Ghani, M., & Ruby, R. (2026). Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization ( STOP DIABETES ). Diabetes, Obesity and Metabolism, 28(7), 5696-5703. https://doi.org/10.1111/dom.70762

Vancouver

Armato J, DeFronzo RA, Abdul-Ghani M, Ruby R. Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization ( STOP DIABETES ). Diabetes, Obesity and Metabolism. 2026;28(7):5696-5703. doi:10.1111/dom.70762

BibTeX
@article{Armato2026,
  author = {Armato, John and DeFronzo, Ralph A and Abdul-Ghani, Muhammad and Ruby, Ron},
  title = {Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization ( STOP DIABETES )},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {7},
  pages = {5696--5703},
  doi = {10.1111/dom.70762}
}
Kostenlos starten →